Investigational Drug Information for Dexanabinol
✉ Email this page to a colleague
What is the drug development status for Dexanabinol?
Dexanabinol is an investigational drug.
There have been 5 clinical trials for Dexanabinol.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2001.
The most common disease conditions in clinical trials are Neoplasms, Wounds and Injuries, and Brain Injuries, Traumatic. The leading clinical trial sponsors are e-Therapeutics PLC, Pharmos, and Santosh Kesari, M.D., Ph.D.
Summary for Dexanabinol
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 373 |
| WIPO Patent Applications | 267 |
| Japanese Patent Applications | 130 |
| Clinical Trial Progress | Phase 3 (2001-01-01) |
| Vendors | 32 |
Recent Clinical Trials for Dexanabinol
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours | e-Therapeutics PLC | Phase 1 |
| Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects | e-Therapeutics PLC | Phase 1 |
| Dexanabinol in Patients With Brain Cancer | e-Therapeutics PLC | Phase 1 |
Clinical Trial Summary for Dexanabinol
Top disease conditions for Dexanabinol
Top clinical trial sponsors for Dexanabinol
US Patents for Dexanabinol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
